Bioactivity:

Lapatinib is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent ac

CAS nr:

388082-78-8

Purity:

98%

Molecular Weight:

943,47

SMILES:

n1cnc(c2cc(ccc12)c1oc(cc1)CNCCS(=O)(=O)C)Nc1cc(c(cc1)OCc1cc(ccc1)F)Cl.c1(ccc(cc1)C)S(=O)(=O)O.O.c1(ccc(cc1)C)S(=O)(=O)O

Formula:

C29H26ClFN4O4S�2(C7H8O3S)�H2O

Pathway:

Autophagy,Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling,Cell Cycle/Checkpoint,Apoptosis

Target:

Autophagy,EGFR,EGFR,EGFR,Ferroptosis,Ferroptosis